Pseudomonas aeruginosa biofilms in cystic fibrosis.

By Niels Høiby, O. Ciofu, T. Bjarnsholt. Future Microbiology, 2010

694 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

RNA target highlights in CASP15: Evaluation of predicted models by structure providers (2023, background): “64 The acute and chronic virulence of P. aeruginosa could be regulated by types III and VI secretion systems, 65,66 biofilm formation, 67 and quorum sensing, a cell density-based intercellular communication network.”
Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. (2015, background): “, 2008), leading to chronic inflammation and lung tissue damage (Høiby et al., 2010).”
Horizontal Gene Exchange in Environmental Microbiota (2011, background): “…July 2011 | Volume 2 | Article 158 | 7 formation is linked to the pathology of many infectious diseases, and biofilms are notoriously difficult to eradicate because of the increased level of resistance to antibiotics (Stewart and Costerton, 2001; Anderson and O’Toole, 2008; Høiby et al., 2010a).”
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. (2013, background): “These lung infections are typically characterized by inflammation and tissue damage, as well as antibiotic and phagocytosis resistance [11,12].”